COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 20 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,671,963 | -30.0% | 300,173 | +2.5% | 0.14% | -17.3% |
| Q2 2023 | $2,388,619 | +17.4% | 292,723 | +1.0% | 0.17% | +16.9% |
| Q1 2023 | $2,034,374 | +84771.7% | 289,797 | +0.9% | 0.15% | -20.9% |
| Q4 2022 | $2,397 | -99.9% | 287,147 | +0.3% | 0.19% | +20.6% |
| Q3 2022 | $1,946,000 | -8.9% | 286,197 | +7.2% | 0.16% | -3.1% |
| Q2 2022 | $2,135,000 | -28.5% | 266,897 | +0.3% | 0.16% | -9.6% |
| Q1 2022 | $2,984,000 | -29.0% | 265,997 | +3.6% | 0.18% | -26.6% |
| Q4 2021 | $4,202,000 | +0.2% | 256,872 | +3.5% | 0.24% | -1.2% |
| Q3 2021 | $4,193,000 | -20.0% | 248,150 | +0.4% | 0.24% | -13.2% |
| Q2 2021 | $5,244,000 | – | 247,250 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 563,030 | $11,942,000 | 13.95% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 530,104 | $11,243,000 | 2.16% |
| FRIESS ASSOCIATES LLC | 235,092 | $4,986,000 | 1.88% |
| Weil Company, Inc. | 30,468 | $646,000 | 0.33% |
| VILLERE ST DENIS J & CO LLC | 247,250 | $5,244,000 | 0.28% |
| ACT CAPITAL MANAGEMENT, LLC | 7,500 | $160,000 | 0.08% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 64,634 | $1,371,000 | 0.07% |
| FNY Investment Advisers, LLC | 4,000 | $84,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 597 | $13,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,800 | $441,000 | 0.00% |